196 related articles for article (PubMed ID: 2180760)
1. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity.
Ward GM; Walters JM; Aitken PM; Best JD; Alford FP
Diabetes; 1990 Apr; 39(4):501-7. PubMed ID: 2180760
[TBL] [Abstract][Full Text] [Related]
2. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
3. Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs.
Davis SN; Dobbins R; Colburn C; Tarumi C; Jacobs J; Neal D; Cherrington AD
Am J Physiol; 1993 May; 264(5 Pt 1):E748-55. PubMed ID: 8498496
[TBL] [Abstract][Full Text] [Related]
4. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man.
Verdin E; Castillo M; Luyckx AS; Lefebvre PJ
Diabetes; 1984 Dec; 33(12):1169-74. PubMed ID: 6389233
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity.
Marangou AG; Weber KM; Boston RC; Aitken PM; Heggie JC; Kirsner RL; Best JD; Alford FP
Diabetes; 1986 Dec; 35(12):1383-9. PubMed ID: 3533684
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man.
Courtney CH; Atkinson AB; Ennis CN; Sheridan B; Bell PM
Metabolism; 2003 Aug; 52(8):1050-5. PubMed ID: 12898472
[TBL] [Abstract][Full Text] [Related]
7. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Osei K
Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
[TBL] [Abstract][Full Text] [Related]
8. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
[TBL] [Abstract][Full Text] [Related]
9. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term pulsatile and continuous insulin delivery on glucagon secretion and insulin secretion and action.
Ward GM; Marangou AG; Best JD; Aitken PM; Alford FP
Metabolism; 1989 Apr; 38(4):297-302. PubMed ID: 2657320
[TBL] [Abstract][Full Text] [Related]
11. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
Lewis GF; Vranic M; Harley P; Giacca A
Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
[TBL] [Abstract][Full Text] [Related]
13. Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects.
Kern W; Fittje A; Fohr W; Kerner W; Born J; Fehm HL
Exp Clin Endocrinol Diabetes; 2000; 108(8):498-505. PubMed ID: 11149624
[TBL] [Abstract][Full Text] [Related]
14. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
15. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique.
Robertson DA; Singh BM; Nattrass M
Diabet Med; 1991 Oct; 8(8):718-25. PubMed ID: 1838062
[TBL] [Abstract][Full Text] [Related]
16. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
Walters JM; Ward GM; Barton J; Arackal R; Boston RC; Best JD; Alford FP
Metabolism; 1997 Dec; 46(12):1448-53. PubMed ID: 9439541
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
Newman WP; Brodows RG
J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
[TBL] [Abstract][Full Text] [Related]
18. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
[TBL] [Abstract][Full Text] [Related]
19. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.
Schmitz O; Pedersen SB; Mengel A; Pørksen N; Bak J; Møller N; Richelsen B; Alberti KG; Butler PC; Orskov H
Metabolism; 1994 Jul; 43(7):842-6. PubMed ID: 7913205
[TBL] [Abstract][Full Text] [Related]
20. Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man.
Abildgaard N; Orskov L; Petersen JA; Alberti KG; Schmitz O; Møller N
Diabet Med; 1995 Mar; 12(3):218-23. PubMed ID: 7758257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
